BPMC
Blueprint Medicines Corporation · Healthcare · Biotechnology
Momentum-Eingaben (vergleichbare Manager):
Halterbreite -8.3% ·
Aktienfluss -1.2% ·
neue Nettopositionen -9.1%
— Formel
Breite Distribution — sinkende Anteile und weniger Halter
Alle Eigentumszahlen: nur beobachtete 13F-Manager, Stammaktienpositionen, Berichtszeitraum Q3 2024
| Quartal | Inhaber | Δ | Aktien | Gemeldeter Wert | Neu | Ausstiege |
|---|---|---|---|---|---|---|
| Q2 2025 | 18 | +4 | 21.31M | $2.73B | +5 | −1 |
| Q1 2025 | 11 | -3 | 14.87M | $1.32B | — | −3 |
| Q4 2024 | 14 | +2 | 17.34M | $1.51B | +2 | — |
| Q3 2024 | 11 | -1 | 13.35M | $1.23B | — | −1 |
| Q2 2024 | 12 | — | 13.51M | $1.46B | — | — |
| # | Manager | Aktien | Δ Anteile | Wert | Deren Gewichtung | Gehalten | ||
|---|---|---|---|---|---|---|---|---|
| 1 | T. Rowe Price ✦ | 5.39M | -8.3% | $498.32M | 0.1% | ▼ Trim | 2 | SEC ↗ |
| 2 | T. Rowe Price ✦ | 5.39M | -8.3% | $498.32M | 0.1% | ▼ Trim | 2 | SEC ↗ |
| 3 | Wellington Management ✦ | 3.96M | +22.5% | $366.73M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 4 | Wellington Management ✦ | 3.96M | +22.5% | $366.73M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 5 | Wellington Management ✦ | 3.96M | +22.5% | $366.73M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 6 | Wellington Management ✦ | 3.96M | +22.5% | $366.73M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 7 | Wellington Management ✦ | 3.96M | +22.5% | $366.73M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 8 | Wellington Management ✦ | 3.96M | +22.5% | $366.73M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 9 | Wellington Management ✦ | 3.96M | +22.5% | $366.73M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 10 | Wellington Management ✦ | 3.96M | +22.5% | $366.73M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 11 | Geode Capital Management ✦ (passiv) | 1.48M | +1.4% | $136.94M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 12 | Geode Capital Management ✦ (passiv) | 1.48M | +1.4% | $136.94M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 13 | Millennium Management ✦ | 618.79K | -1.4% | $57.24M | 0.1% | ▼ Trim | 2 | SEC ↗ |
| 14 | Norges Bank ✦ (passiv) | 603.23K | +1.9% | $55.80M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 15 | Fisher Asset Management ✦ | 335.35K | -0.2% | $31.02M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 16 | Marshall Wace ✦ | 333.77K | -5.1% | $30.87M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 17 | D. E. Shaw & Co. ✦ | 255.69K | -15.5% | $23.65M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 18 | D. E. Shaw & Co. ✦ | 255.69K | -15.5% | $23.65M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 19 | Renaissance Technologies ✦ | 174.50K | +58.1% | $16.14M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 20 | AQR Capital Management ✦ | 114.06K | +46.0% | $10.55M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 21 | AQR Capital Management ✦ | 114.06K | +46.0% | $10.55M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 22 | AQR Capital Management ✦ | 114.06K | +46.0% | $10.55M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 23 | Citadel Advisors ✦ | 77.86K | +98.6% | $7.20M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 24 | Citadel Advisors ✦ | 77.86K | +98.6% | $7.20M | 0.0% | ▲ Add | 2 | SEC ↗ |
„Ihre Gewichtung" = Anteil der Position am gemeldeten 13F-Eigenkapitalwert des jeweiligen Managers — das Conviction-Maß. ✦ = kuratorisch ausgewählter Manager.
Neue Käufer
| Keine neu erfassten Käufer in diesem Quartal. |
Ausgestiegen
| Point72 Asset Management | $54.06M | war 0.2% |
Marktweiter Kontext: über ALLE 13F-Melder (strukturierte SEC-Daten, Q1 2026): 2 Inhaber, 301 Anteile, $38,583 gemeldet. Dies ist ein anderer, älterer Zeitraum als die oben genannten Zahlen des erfassten Universums; beide werden niemals vermischt.
Was die erfassten Halter dieses Wertpapiers am häufigsten sonst noch halten — Zählungen gemeinsamer Eigentümerschaft, keine fundamentalen Zusammenhänge.